Definitive Contract HHSD200201587862C
- Not listed
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for $125,123.27 in firm fixed-price laboratory analysis services. It has a completion date of September 15, 2023. Emory University is the prime contractor on this contract, which is not set aside for any specific socioeconomic category. Emory is a major recipient of federal research contracts and grants,...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for laboratory analysis services with a firm fixed price of $77,297.50 and a completion date of September 14, 2023. Emory University has an extensive track record of performing federally funded research and providing services to the government, including work for the CDC...
- This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
- This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University. The contract, valued at $630,506.00, is for services performed under the 2019 Broad Agency Announcement (BAA) and has a completion date of May 15, 2022. Emory University is a private research university that has an extensive track record of performing federally funded research and providing services to the government...
- This is a $450,000.00 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract is for HIV research and has a period of performance through December 31, 2024. Emory University, through its Office of Sponsored Programs Division, has an extensive track record of conducting federally funded research for government agencies, particularly in the areas of biomedical research, public...
- This firm fixed-price purchase order was awarded to Emory University, a private research institution in Atlanta, Georgia, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $90,000.00 contract is for an IRB-approved study under the Emory University Center for AIDS Research. The contract has no set-aside designation and is set to be completed by September 20, 2022. Emory University, through its Office of Sponsored Programs Division, has an extensive track record of...
- This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
- The federal contract award, ID 75D30123C16926, was granted to Emory University by the Centers for Disease Control and Prevention (CDC) for a Broad Agency Announcement (BAA) topic 33.1. The $1,807,738.00 Firm Fixed Price contract has a completion date of September 10, 2026. Emory University, a private research university in Atlanta, Georgia, will provide products and services under this contract through its Office of Sponsored Programs Division. The contract is not set aside for any specific...
- The federal contract award 75D30121C10084 was issued by the Centers for Disease Control and Prevention (CDC) to Emory University for "SARS - COV-2 APPLIED RESEARCH FOR NCEZID". The $622,108.90 firm-fixed price contract runs through November 28, 2022 and does not have a set-aside designation. Emory University, a private research university based in Atlanta, Georgia, has an extensive track record of performing federally funded research and providing services to the government. This...
- This firm-fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract, valued at $245,000.00, is for a TAF-EVG INSERT STUDY and has an ultimate completion date of September 28, 2025. Emory University, a major recipient of federal funding, is known for its expertise in biomedical research, public health, and healthcare innovation. This contract does not have a...
This is a $10,168,423.08 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia, for the provision of clinic care services. The contract has an ultimate completion date of August 31, 2020 and is a cost-no-fee arrangement. Emory University is a major recipient of federal contracts and grants, with an extensive track record of conducting biomedical research, public health, and clinical studies for government agencies. This contract is part of Emory's broader portfolio of federal work, which includes an Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID) valued at up to $146,300,000 for the development and refinement of pre-clinical models of infectious diseases. The CDC contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 9 | Other Administrative Action | ($379k) | 3/31/22 | |
| 8 | Exercise an Option | $1.4m | 7/1/19 | |
| 7 | Supplemental Agreement for work within scope | $250.0k | 9/4/18 | |
| 6 | Exercise an Option | $1.4m | 7/26/18 | |
| 5 | Other Administrative Action | $0 | 5/9/18 |